Maroon Biotech has developed a new category of pharmaceuticals called surfactant chaperones. This technology has the capability to restore structure and viability to cells disrupted by physical and chemical trauma.

Maroon’s surfactant chaperone technology can actually reduce the amount of brain tissue damaged by the lack of oxygen during a stroke. As the third leading cause of death in the United States today, Maroon will be able to make a difference in the lives of hundreds of thousands of people each year.

Current and ongoing combat has taken the lives of countless soldiers and civilians all over the world. Maroon has the technology to not only help save the lives of people sustaining injuries from military trauma, but to also heal any damaged tissue that would lead to permanent disabilities if left untreated.